AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Everad 0.25 Tablet

Prescription Icon
Prescription Required

Marketer

Biowision Life Sciences Pvt Ltd

Salt Composition

Everolimus (0.25mg)

Overview Everad 0.25 Tablet

Everad 0.25mg tablets prevent organ rejection in transplant recipients by modulating the immune system's reaction, facilitating organ acceptance. This medication also features in combination therapies for breast, pancreatic, lung, and kidney cancers. Adhere strictly to your physician's prescribed dosage and regimen. Administration with or without food is acceptable, but maintain consistent daily timing. Overdosage carries significant health risks. Common adverse effects encompass infection, pyrexia, cough, lassitude, diarrhea, and upper respiratory tract infections. Persistent or troubling side effects necessitate immediate medical attention. Report allergic reactions (e.g., rash, dyspnea, cough, edema) immediately. Seek medical counsel for increased thirst or urination frequency, dyspnea, cough, fever, or pre-vaccination considerations. Prior to commencing treatment, disclose all existing medications and underlying conditions to your doctor. Pregnant or lactating individuals must inform their physician before starting Everad 0.25mg. Your doctor might order blood tests to monitor the drug's effects. Potential impacts on male or female fertility warrant discussion with your doctor if family planning is underway.

Uses of Everad 0.25 Tablet

Avoiding transplant organ rejection

Major Benefits of Everad 0.25 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Everad 0.25 Tablet whole; do not damage it in any way. While it can be taken with or without food, consistency is key—take it at the same time each day.

Common Side effects of Everad 0.25 Tablet:

  • Infection
  • Fever
  • Cough
  • Fatigue
  • Diarrhea
  • Upper respiratory tract infection

How to use Everad 0.25 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Everad 0.25mg Tablets can be administered with or without food, although consistent timing is recommended.

How Everad 0.25 Tablet works:

Everad 0.25mg tablets modulate the body's immune response, thereby hindering organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Everad 0.25 Tablet may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Everad 0.25mg tablets during pregnancy carries a confirmed risk to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Everad 0.25 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Everad 0.25 Tablet side effects, including the common side effect of fatigue.

KidneyKidneySAFE IF PRESCRIBED

Everad 0.25mg tablets may be administered to patients with renal impairment without the need for dosage modification.

LiverLiverCAUTION

Patients with liver impairment should use Everad 0.25mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Everad 0.25mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Everad 0.25 Tablet :

NA

Facts to Know About Everad 0.25 Tablet

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Type of Treatment Cancer therapeutics

FAQs on Everad 0.25 Tablet

Consistent oversight is necessary during Everad 0.25 Tablet therapy. Your physician will order blood work to assess red blood cell, white blood cell, and platelet levels, as these may decline with Everad 0.25 Tablet use. Furthermore, blood tests will monitor kidney and liver function, blood glucose, and cholesterol.
Concurrent use of Everad 0.25 Tablet and grapefruit or grapefruit juice should be avoided. This combination can elevate Everad 0.25 Tablet blood levels to potentially dangerous concentrations. Furthermore, live vaccines and contact with recently vaccinated individuals must be avoided.
Taking Everad 0.25 Tablets may result in serious adverse events, potentially including life-threatening allergic reactions like angioedema and acute kidney injury. Respiratory complications, including breathing difficulties, and infections are also possible.
Everad 0.25mg tablets are a cancer medication categorized as a kinase inhibitor. Their mechanism of action involves diminishing tumor blood flow, thereby hindering cancer cell proliferation and metastasis.
Everad 0.25 mg tablets are typically administered once or twice a day. Consistent administration is key—either always with food or always without. The tablet should be swallowed intact with water; crushing or chewing is not recommended.
Treatment length for Everad 0.25 Tablet isn't fixed. Its use continues until clinical improvement is observed or intolerable adverse reactions develop.
Regular brain scans are necessary to monitor the impact of Everad 0.25 Tablet on tumor reduction. This monitoring should adhere to your physician's recommendations and prescribed treatment schedule.
Everad 0.25mg tablets demonstrate cytotoxic activity against cancerous cells originating in the breast, stomach, prostate, and kidneys (renal cell carcinoma).
Everad 0.25 Tablet
574
MRP 699
17% off